(Q42162266)

17 October 2017

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study (English)

1 reference

17 October 2017

1 reference

neoadjuvant chemotherapy

1 reference

1 reference

3

1 reference

17 October 2017

2

Michael Untch

1 reference

17 October 2017

Kerstin Hermelink

1

1 reference

17 October 2017

Rolf Kreienberg

4

1 reference

17 October 2017

Thomas Beck

5

1 reference

17 October 2017

Ingo Bauerfeind

6

1 reference

17 October 2017

Karin Münzel

7

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

17 October 2017

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

17 October 2017

109

1 reference

17 October 2017

9

1 reference

17 October 2017

1905-1913

1 reference

What do cancer patients mean when they complain of concentration and memory problems?

17 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Cognitive impairment associated with adjuvant therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Cognitive effects of standard-dose chemotherapy in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Trail making test: normative values from 287 normal adult controls.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Trail Making Test A and B: normative data stratified by age and education

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Test-retest reliability and practice effects of a rapid screen of mild traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Assessment of cognitive deterioration in individual patients following cardiac surgery: correcting for measurement error and practice effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

'Chemobrain' in breast carcinoma?: a prologue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Stress response syndromes and cancer: conceptual and assessment issues.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Neurocognitive functioning in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22610

7 January 2021

Identifiers

DOI

10.1002/CNCR.22610

1 reference

release_nj45pee3nrgmdbyv3jt5zg535m

17 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nj45pee3nrgmdbyv3jt5zg535m

24 November 2022

mapped directly with Wikidata item

1 reference